Literature DB >> 15623700

Correlations between molecular profile and radiologic pattern in oligodendroglial tumors.

F Laigle-Donadey1, N Martin-Duverneuil, J Lejeune, E Crinière, L Capelle, H Duffau, P Cornu, P Broët, M Kujas, K Mokhtari, A Carpentier, M Sanson, K Hoang-Xuan, J Thillet, J Y Delattre.   

Abstract

OBJECTIVE: To investigate possible correlations between tumor location and genetic alterations in a series of oligodendrogliomas.
METHODS: A series of 158 consecutive oligodendrogliomas were retrospectively reviewed. In each case, the radiologic picture and the chromosome 1p (chr 1p) status of the tumor detected by the loss of heterozygosity technique were analyzed. Correlation between tumor location and molecular profile was made by chi2 tests.
RESULTS: Eighty-eight of the 158 patients had low-grade oligodendrogliomas, and 70 had anaplastic oligodendrogliomas. Overall, oligodendrogliomas with chr 1p loss were located preferentially in the anterior part of the brain, whereas tumors with intact chr 1p affected mainly the posterior part of the brain (p = 0.0038). In terms of lobar involvement, a preferential location of oligodendrogliomas with chr 1p loss was found in the frontal lobes as compared with the temporal, parietal, and occipital tumors (p < 0.01).
CONCLUSION: There is a significant correlation between loss of heterozygosity on chromosome 1p and tumor location in oligodendrogliomas, suggesting that subtypes of oligodendrogliomas could derive from site-specific precursors.

Entities:  

Mesh:

Year:  2004        PMID: 15623700     DOI: 10.1212/01.wnl.0000148642.26985.68

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

1.  Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation.

Authors:  Y Y Wang; K Wang; S W Li; J F Wang; J Ma; T Jiang; J P Dai
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-27       Impact factor: 3.825

2.  Radiological features of supratentorial gliomas are associated with their genetic aberrations.

Authors:  Yuya Nishiyama; Hikaru Sasaki; Shinya Nagahisa; Kazihide Adachi; Takuro Hayashi; Koichiro Yoshida; Tsukasa Kawase; Natsuki Hattori; Kazuhiro Murayama; Masato Abe; Mitsuhiro Hasegawa; Yuichi Hirose
Journal:  Neurosurg Rev       Date:  2013-12-21       Impact factor: 3.042

3.  Prognostic Significance of Anatomic Origin and Evaluation of Survival Statistics of Astrocytoma Patients-a Tertiary Experience.

Authors:  Ravindra Pramod Deshpande; Chandrasekhar Y B V K; Manas Panigrahi; Phanithi Prakash Babu
Journal:  Indian J Surg Oncol       Date:  2018-10-30

4.  A better surgical resectability of WHO grade II gliomas is independent of favorable molecular markers.

Authors:  Dominik Cordier; Catherine Gozé; Sabine Schädelin; Valérie Rigau; Luigi Mariani; Hugues Duffau
Journal:  J Neurooncol       Date:  2014-09-28       Impact factor: 4.130

Review 5.  Biology, genetics and imaging of glial cell tumours.

Authors:  C Walker; A Baborie; D Crooks; S Wilkins; M D Jenkinson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 6.  Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers.

Authors:  Michael Jansen; Stephen Yip; David N Louis
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

7.  "Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.

Authors:  Rajan Jain; Derek R Johnson; Sohil H Patel; Mauricio Castillo; Marion Smits; Martin J van den Bent; Andrew S Chi; Daniel P Cahill
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

8.  IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas.

Authors:  Amélie Darlix; Jérémy Deverdun; Nicolas Menjot de Champfleur; Florence Castan; Sonia Zouaoui; Valérie Rigau; Michel Fabbro; Yordanka Yordanova; Emmanuelle Le Bars; Luc Bauchet; Catherine Gozé; Hugues Duffau
Journal:  J Neurooncol       Date:  2017-04-22       Impact factor: 4.130

9.  Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients.

Authors:  Fausto J Rodriguez; Tarik Tihan; Doris Lin; William McDonald; Janice Nigro; Burt Feuerstein; Sadhana Jackson; Kenneth Cohen; Peter C Burger
Journal:  Am J Surg Pathol       Date:  2014-08       Impact factor: 6.394

10.  TERT promoter mutated WHO grades II and III gliomas are located preferentially in the frontal lobe and avoid the midline.

Authors:  Ze-Lin Sun; Aden Ka-Yin Chan; Ling-Chao Chen; Chao Tang; Zhen-Yu Zhang; Xiao-Jie Ding; Yang Wang; Chong-Ran Sun; Ho-Keung Ng; Yu Yao; Liang-Fu Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.